Association between Lp-PLA2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis
- 1 September 2005
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 182 (1) , 181-188
- https://doi.org/10.1016/j.atherosclerosis.2004.10.046
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular diseaseCurrent Opinion in Lipidology, 2003
- Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolaseAtherosclerosis Supplements, 2002
- Platelet-Activating Factor Acetylhydrolase (PAF-AH)The Journal of Biochemistry, 2002
- Lp-PLA2: an emerging biomarker of coronary heart diseaseExpert Review of Molecular Diagnostics, 2002
- Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery diseaseAtherosclerosis, 2000
- Modified LDL – trigger of atherosclerosis and inflammation in the arterial intimaJournal of Internal Medicine, 2000
- Lipoprotein-Associated Phospholipase A 2 , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Cellular Source(s) of Platelet-Activating-Factor Acetylhydrolase Activity in PlasmaBiochemical and Biophysical Research Communications, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Platelet-activating Factor AcetylhydrolasesPublished by Elsevier ,1997